Member Info for dickie3times

15p next week...when the REAL HERD arrives. Many are still grazing on old pastures....until they realise this is greener?

Those that got in early have donr
well....
Those getting in now could fare better...
Why's dat?
Well, early investors tend to take early profits incase of any retrace, leaving later investors to ride the bigger rises yet to come?
And good on those still holding?
My vicar who is also a part time investment advisor suggested i should HOLD BUY HOLD abd don't take profits yet. "Best little stock in Christendom." He said

Happy with my my buy
649,600 @ 0.393p cost £2,500

This is the longest at 0 39p

If it drops any more and holds..... then a rush to buy or will pi's hold off for even lower...?
I'm tempted but inclined to wait a bit longer...?
GLA....

Good news TommyBoy..
Looks like we could be trading in early January. Or at least Q1 2023 ?

HOPE for trading by end of this year ???

STARK Resources
Bergbau
STARK is a global integrator of smart solutions for mineral processing and modular solutions.
Folgen

Stark is a privately owned global engineering solutions company. We are integrators of smart solutions for mineral processing. Our global team consists of the most experienced engineers and specialists in sensor-based sorting applications for mineral processing- original pioneers who spent over two decades learning how to solve today’s mining problems while embracing new technologies.

STARK transforms, builds, and upgrades smart mineral processing. We initially assess through studies to find the best way forward. We then make the solutions easy to integrate with our cost-effective modular plant elements that can be installed in a record time and ensure plant optimization through Stark RFID tracking and tracer systems.

We are STARK: Smart. Simple. Fast.

Website
https://stark-resources.com/
Branchenbb

Awrsome company....

Look at PREM and POLB....both will outperform th7s year and 2023.m
I am invested

..Awe inspiring...

Jeremy Skillington, PhD, CEO of Poolbeg Pharma said: "We are grateful for the support of the Irish Government in awarding this funding and delighted to be working with our consortium of high-quality partners in University College Dublin, Trinity College Dublin and AnaBio. The funding will support the progression of this exciting oral vaccine platform that has the potential to improve the ways vaccines are manufactured, distributed and administered for the future. Poolbeg continues to target non-dilutive funding opportunities and we are delighted that this DTIF award is our first success."

Prof Siobhán McClean, Associate Professor at University College Dublin ("UCD") said: "I am pleased to work with the other members of this consortium to bring the antigens my team have identified and developed, closer to the clinic so that together, we can protect people from infectious diseases."

Prof Ed Lavelle, Professor of Immunology at Trinity College Dublin ("TCD") said: "The pharmaceutical industry has long aspired to develop subunit oral vaccines and I believe we have assembled a consortium of experts and ground-breaking technologies that are uniquely placed to make them a reality."

Dr Sinéad Bleiel, Founder & Chief Scientific Officer of AnaBio Technologies said: "Having demonstrated the potential of our encapsulation technology to deliver drug products safely and effectively to the gut, we are excited to collaborate with the EncOVac team of world class researchers, led by Poolbeg and supported by the Irish Government as part of the world's renewed fight against infectious diseases."

Prof Luke O'Neill, Non-Executive Director, Scientific Advisory Board and Project Advisory Board Chair said: "Oral vaccines are currently only available to treat a small number of pathogens and a more comprehensive approach to vaccine development is needed to design new, safe, and effective oral vaccines. Such a system would revolutionise our approach to protecting people from infectious diseases, unleashing their full potential."

Tut tut typos...sorry

I agree with yayay...FFS why do posters keep pushing the goalposts further away. EVERYONE knows that the easiest way to stop investors in their tracks is simply to mention time scales that are years away?
The more people believe it will be years...THE MORE THAT GIVE UP.
If nothing is to happen for 2-3 years, then i'll be off as well.
Too many better opportunities out there bringing in immediate profits. Even 3 months is too long for some after being invested for a few years.
Hanging on...it's all subtle deramping...?
GLA
2025 is schitt ffs?

I agree with yayay...FFS why do posters keep pushing the goalposts further away. EVERYONE knows that the easy wayctovdtop investors in thrir tracks is simply mention time scales thstcare years away. The more people believe it will be years...THE MORE THAT GIVE UP.
If nothing is to happen for 3ç years, then i'll be off as well. Too many better opportunities out there bringing in immediate profits. Even 3 months is too long for most after being invested for a few years.
Hanging on...
GLA
2025 is schitt ffs?

A going concern or rather concern this is going?

If they cannot sevure contract eith huge sales it would be difficilt for thr market to see NNN ad a going concern. Especially if other countrues are manufacturing for themselves. Govt contracts needed...and promply?
Imo

Taken from HVO posted by silverhorse

https://www.investorschronicle.co.uk/alpha/2022/11/17/ride-the-boom-in-vaccine-research/

has been a material increase in pharmaceutical research and development (R&D) activity in infectious diseases during and after the Covid-19 pandemic. However, there are still only 26 infectious diseases that are preventable by available vaccines, according to the World Health Organisation.

Given the costs involved, and the fact that the vast majority of vaccine programmes fail, the drug industry is striving to get smarter in the way it develops vaccines. One way to mitigate risk is to conduct human challenge clinical trials as part of the development process. It’s a buoyant niche business that is driving huge demand for the services of one below the radar small-cap company. For good measure, its shares are materially undervalued.

https://www.investegate.co.uk/poolbeg-pharma-plc--polb-/eqs/poolbeg-pharma-makes-virus--breakthrough--using-ai-drug-discovery-technology/20221109135159EXFNV/

DYOR...agreed. Just watched this from 9th Nov.
Impressive

https://youtu.be/bGQMow2rspk

Thanks Moniman...good advice.

The silence is deafening?
Lol

Moniman.....what do investors think of HVO....I have read recent news. Have i missed the boat ir is there further to go. Must say Hvo look impressive?